Amundi Pioneer Asset Management Inc. Has $202.71 Million Stock Holdings in Citigroup Inc (NYSE:C)

Amundi Pioneer Asset Management Inc. lessened its position in shares of Citigroup Inc (NYSE:C) by 6.2% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 3,257,966 shares of the financial services provider’s stock after selling 214,045 shares during the quarter. Amundi Pioneer Asset Management Inc. owned about 0.14% of Citigroup worth $202,711,000 as of its most recent SEC filing.

A number of other large investors have also recently added to or reduced their stakes in the stock. Norges Bank acquired a new position in shares of Citigroup in the fourth quarter worth $1,383,526,000. ValueAct Holdings L.P. grew its position in shares of Citigroup by 20.2% in the fourth quarter. ValueAct Holdings L.P. now owns 31,525,500 shares of the financial services provider’s stock valued at $1,641,218,000 after purchasing an additional 5,300,000 shares during the period. Lakewood Capital Management LP grew its position in shares of Citigroup by 75.1% in the fourth quarter. Lakewood Capital Management LP now owns 6,071,500 shares of the financial services provider’s stock valued at $316,082,000 after purchasing an additional 2,605,000 shares during the period. CI Investments Inc. grew its position in shares of Citigroup by 113.5% in the fourth quarter. CI Investments Inc. now owns 3,414,800 shares of the financial services provider’s stock valued at $177,774,000 after purchasing an additional 1,815,543 shares during the period. Finally, SG Americas Securities LLC grew its position in shares of Citigroup by 106.2% in the first quarter. SG Americas Securities LLC now owns 84,439 shares of the financial services provider’s stock valued at $5,254,000 after purchasing an additional 1,456,722 shares during the period. Hedge funds and other institutional investors own 75.98% of the company’s stock.

In other Citigroup news, CEO Stephen Bird sold 30,000 shares of the firm’s stock in a transaction dated Monday, April 22nd. The shares were sold at an average price of $69.33, for a total transaction of $2,079,900.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. 0.09% of the stock is owned by company insiders.

Shares of NYSE C traded up $0.97 during mid-day trading on Thursday, hitting $71.79. The company had a trading volume of 12,981,160 shares, compared to its average volume of 15,093,158. The company has a debt-to-equity ratio of 1.40, a quick ratio of 1.01 and a current ratio of 1.01. The firm’s 50-day moving average price is $68.38. Citigroup Inc has a 12 month low of $48.42 and a 12 month high of $75.24. The company has a market cap of $163.77 billion, a price-to-earnings ratio of 10.80, a P/E/G ratio of 0.78 and a beta of 1.74.

Citigroup (NYSE:C) last released its earnings results on Monday, July 15th. The financial services provider reported $1.95 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.78 by $0.17. The business had revenue of $18.76 billion during the quarter, compared to analysts’ expectations of $18.49 billion. Citigroup had a net margin of 18.24% and a return on equity of 10.10%. The firm’s revenue was up 1.6% on a year-over-year basis. During the same quarter last year, the company earned $1.63 earnings per share. Analysts anticipate that Citigroup Inc will post 7.51 EPS for the current fiscal year.

A number of brokerages have commented on C. UBS Group reduced their price objective on Spotify from $182.00 to $180.00 and set a “buy” rating on the stock in a research note on Tuesday, April 16th. Morgan Stanley cut GasLog Partners LP Unit from an “overweight” rating to an “equal weight” rating and reduced their price objective for the stock from $23.00 to $18.00 in a research note on Tuesday, April 16th. Oppenheimer set a $15.00 price objective on Strongbridge Biopharma and gave the stock a “buy” rating in a research note on Tuesday, March 26th. Barclays cut Barrick Gold from an “overweight” rating to an “equal weight” rating and upped their price objective for the company from $15.00 to $18.00 in a research note on Tuesday. Finally, ValuEngine cut Acceleron Pharma from a “strong-buy” rating to a “buy” rating in a research note on Thursday, April 18th. Five equities research analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus price target of $78.90.

Citigroup Company Profile

Citigroup Inc, a diversified financial services holding company, provides various financial products and services for consumers, corporations, governments, and institutions in North America, Latin America, Asia, Europe, the Middle East, and Africa. The company operates through two segments, Global Consumer Banking (GCB) and Institutional Clients Group (ICG).

Further Reading: What is the float in trading stocks?

Institutional Ownership by Quarter for Citigroup (NYSE:C)

Receive News & Ratings for Citigroup Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Citigroup and related companies with MarketBeat.com's FREE daily email newsletter.